Skin protection study comparing a new dressing to no treatment
Part of Skin clinical trials.
This study tests a new liquid dressing (a protective layer that goes on the skin) applied to the forearm. It compares the treated area with an untreated area to see how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have healthy skin on both forearms (no skin diseases like vitiligo, psoriasis, or eczema).
- You must not be pregnant or breastfeeding.
- You must not have immune system problems or be taking medications that weaken the immune system.
- You must not have type 1 diabetes or insulin-dependent diabetes with complications.
- You must not have had a reaction to liquid dressings in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a cosmetic product on people with sensitive skin to see how well it is tolerated. If you have sensitive skin, you may find out if this product is suitable for your skin.
This study checks if a new skin product is comfortable and safe for children from newborns to 14-year-olds. It aims to see how well kids tolerate it.
This study tests three experimental bandages to see how well they stick and feel on the back. You may qualify if you have healthy skin and are willing to follow some simple rules about washing and lotions.
This trial tests a new bandage (called Microlyte DualGuard) for the spot on your thigh where skin is taken for a graft. The bandage contains silver and gallium, which may help the wound heal and reduce infection. The study will check if the bandage is safe and how well it works.
This trial tests two different dressings used on the area where a skin graft is taken from (the donor site) to see which one heals better and is more comfortable. If you are having a skin graft, this study compares both dressings on the same wound so you can see which works best.
This trial tests a new cream that may help heal wounds in people with epidermolysis bullosa (EB), a condition causing fragile skin that blisters easily. The cream is applied directly to the wounds, and researchers will compare two similar wounds on the same person to see if the cream works better than a cream without the medicine.
Hear when a new Skin Lesions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.